that is , insurers and large employers with more colorectal cancer screening benefits could have been more likely to participate in our survey than those with fewer colorectal cancer screening test benefits .
colorectal cancer is the second leading cause of cancer deaths in the united states .
over 146,000 new cases of colorectal cancer will be diagnosed and almost 57,000 people will die from the disease in 2004 , according to the american cancer society ( acs ) .
specifically , we determined 1. 	 the extent to which state laws require private health insurance plans to cover the four colorectal cancer tests for screening purposes ; and 2. 	 the extent to which private health insurance plans cover the four colorectal cancer tests for screening purposes , specifically health plans sold by insurers to small employers and individuals in states that do not offered by large employers across the united states , and offered through the federal employees health benefits program ( fehbp ) .
four key tests — fecal occult blood test ( fobt ) , flexible sigmoidoscopy , double - contrast barium enema ( dcbe ) , and colonoscopy — are commonly used to detect colorectal cancer or its symptoms .